In December 2024, Checkpoint announced that the U.S. Food and Drug Administration (“FDA”) approved UNLOXCYT™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell ...
Located 52 miles into the trail Nenana served as the first checkpoint of the 2025 Iditarod. It marks the third time the race passed through the historic mushing town, with previous stops in 2015 and ...
Shares of Checkpoint Therapeutics rose 4.6% to $3.84 in post-market trading after the Food and Drug Administration approved Unloxcyt (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma, ...
Countries including France and the United States condemned the move by Azerbaijan - Copyright AFP Bertrand GUAY Countries including France and the United States ...
WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the first ...